Implantation of Next-Generation AngelMed Guardian in US
Filed with ASX · · 2 pages · English
Earlier from Hydrix
- FY2020 Results Presentation
- FY2020 Results Announcement
- FY2020 Letter from Executive Chairman
- FY2020 Appendix 4E and Financial Report
- First AngelMed Guardian implants in Asia-Pacific
Later from Hydrix
- Update on AngelMed Guardian implants in Singapore
- Trading Halt
- Hydrix raises $10m under institutional placement
- Phyzhon appoints Hydrix as exclusive distributor
- First in human trials of Phyzhon Health PHYRARI FFR-WIRE
Follow Hydrix into a list and get an email when it puts out news.
Follow Hydrix